Literature DB >> 7555204

Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium kansasii.

W Fabry1, E N Schmid, R Ansorg.   

Abstract

The newly developed E test was compared with a conventional proportion dilution method for determining the sensitivity of Mycobacterium kansasii to amikacin, streptomycin, fusidic acid, rifampicin, clarithromycin, ciprofloxacin, ofloxacin, and fleroxacin. There was no more than one strain with different rating, except for ciprofloxacin. In this case, the breakpoint concentration had an unfavourable position at the top of the strip, and susceptible isolates in the dilution test were defined resistant in the E test. It is concluded that the E test is suitable for testing slowly growing mycobacteria other than tubercle bacilli, and may replace the more laborious dilution methods, particularly for testing M. kansasii.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555204     DOI: 10.1159/000239352

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  3 in total

1.  Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.

Authors:  Zofia Bakuła; Magdalena Modrzejewska; Lian Pennings; Małgorzata Proboszcz; Aleksandra Safianowska; Jacek Bielecki; Jakko van Ingen; Tomasz Jagielski
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.

Authors:  J L Klein; T J Brown; G L French
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 3.  Evolution of Antibacterial Drug Screening Methods: Current Prospects for Mycobacteria.

Authors:  Clara M Bento; Maria Salomé Gomes; Tânia Silva
Journal:  Microorganisms       Date:  2021-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.